The C4 is due out to which we already know will show revenue at...

The C4 is due out to which we already know will show revenue at around $1.3m.


I have taken an extract from my SP3 spreadsheet and highlighted a couple of things on my graphs. Revenue Q on Q growth fluctuates wildly. The line of best fit (yellow dotted- first graph) clearly shows a declining growth trend. This bothers me as a holder of over 2m shares in SP3. Particularly in light of the implementation of outbound sales team.

Second graph shows a variation on the theme with Operation expenses graphed against revenue. It is troubling that given outbound sales team commenced implementation in July 2019 and not withstanding Covid, my expectations were that the significant rebound post Covid would translate to much greater revenue than we are currently getting.

Revenue pre Covid and pre Outbound sales team $1.5m/QTR
Revenue post Covid and post Outbound sales team < $1.5m/QTR

From my perspective Q4 FY 2021 will have to be orders of magnitude better than $1.5m as 8 QUARTERS with an investment in outbound sales is more than enough to see it translate to reasonable revenue growth.

I was and am a bullish supporter of this company but the strategy of which I am also very supportive of has begun to show sound evidence of implementation failure . The next 2 quarters will determine my continued investment.

What do others think?